Applied Biosystems/MDS SCIEX teams up with forensic toxicologists to revolutionise drugs of abuse testing

13 Feb 2007

Product news

Scientists from Applied Biosystems/MDS SCIEX in Toronto have teamed up with forensic toxicologists at the Institute of Forensic Medicine, University Hospital Freiburg, in Germany, to develop novel methods that can simultaneously detect between 300 and 400 substances from just one sample of human blood, bodily fluid or hair in under 25 minutes.

The development has huge potential in legal casework and in hospital emergency departments where doctors need to find out urgently what drugs of abuse intoxicated or incapacitated patients may have taken.

Data from the new LC/MS/MS-based analytical methods are being compiled to form a compound library of information and spectral data for hundreds of pharmacologically relevant compounds, including opiates, amphetamines, cannabinoids, benzodiazepines, antidepressants, hypnotics, and many others, which will be invaluable for other forensic toxicologists, chemists and pharmacologists.

Prof Wolfgang Weinmann, forensic toxicologist at the Institute, explained: "The approach we have developed with MDS SCIEX is faster, more sensitive and requires less sample preparation, so is less expensive than traditional HPLC UV or immunoassay-based techniques."

The methods depend on Applied Biosystems/MDS SCIEX Q TRAP® LC/MS/MS technologies, which are ideal for identification, quantitation and confirmation. The hybrid triple quadrupole/linear ion trap Q TRAP Systems provide the unique ability to acquire both quantitative and qualitative information during a single run at the same level of sensitivity and selectivity. The technology makes it possible to acquire a spectral fingerprint in the ion trap mode, which has the advantage of acquiring more fragment rich spectra at a much higher level of sensitivity than that of traditional ion trap or triple quadrupole instruments.

Links

Tags

LC-MSLC-MS (liquid chromatography-mass spectrometry) systems and equipment are used for separation and quantitative analysis of complex mixtures, combining liquid chromatography and mass spectrometry. Quantify proteins, contaminants, pesticides or screen for drug metabolites with a high level of sensitivity. LC-MS systems and equipment include reverse phase, normal phase and specialized columns integrated with various MS detectors such as time-of-flight (TOF), quadrupole, orbitrap or ion trap mass analyzers. LC-MS/MS instruments equipped with a qTOF or triple quadrupole analyzer give greater sensitivity and resolving power to your analysis. Find the best LC-MS equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ADME-ToxicologyADME-toxicology (ADME-Tox) studies are used in pharmacology and pharmacokinetics to assess the activity/toxicity of drugs <i>in vivo</i> or <i>in vitro</i>. Find bioassays for absorption, distribution, metabolism, and excretion of drug molecules including cytotoxicity, transporter/permeability, metabolism and activity assays as well as hepatocytes and cell lines for ADME. Find the best ADME-toxicology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Compound LibrariesCompound libraries, or chemical libraries, are used in drug discovery for the identification of potential therapeutics compounds. Used in conjunction with high-throughput screening, the libraries of stored compounds are often generated for specific purposes as a drug target or disease model. Cheminformatics are commonly used when designing a compound library and software can be used to analyze the screening process.  Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.
Applied Biosystems/MDS SCIEX teams up with forensic toxicologists to revolutionise drugs of abuse testing